Cite
HARVARD Citation
Howell, M. et al. (2017). Bendamustine can be a bridge to allogeneic transplantation in relapsed Hodgkin lymphoma refractory to brentuximab vedotin. British journal of haematology. pp. 841-843. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Howell, M. et al. (2017). Bendamustine can be a bridge to allogeneic transplantation in relapsed Hodgkin lymphoma refractory to brentuximab vedotin. British journal of haematology. pp. 841-843. [Online].